Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. namibia
  4. connective tissue
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Connective Tissue Articles & Analysis

18 news found

Alfa Chemistry Shines as a Premier Recombinant Human Collagen Product Supplier   

Alfa Chemistry Shines as a Premier Recombinant Human Collagen Product Supplier  

In the field of regenerative medicine and tissue engineering, the demand for collagen-based biomaterials is rapidly increasing. Collagen, the most abundant protein in the human body, plays a crucial role in maintaining the structure and function of various tissues. Recognizing the growing need for high-quality collagen products, Alfa Chemistry has emerged as a reliable supplier of recombinant ...

ByAlfa Chemistry


Creative Enzymes Forges New Frontiers in Collagen Innovation

Creative Enzymes Forges New Frontiers in Collagen Innovation

Creative Enzymes, a leading name in biotechnology and enzyme manufacturing, is proud to introduce a range of premium collagen products that promise to revolutionize the health and wellness industry. With a commitment to excellence and scientific innovation, Creative Enzymes is dedicated to providing top-notch collagen solutions that cater to a diverse clientele. Collagen, often referred to as ...

ByCreative Enzymes


BIO Investor Forum Company Snapshot: InvivoSciences

BIO Investor Forum Company Snapshot: InvivoSciences

BIO Investor Forum Company Snapshot: InvivoSciences What is your company’s lead product or technology? InvivoSciences, Inc. (IVS) is a leading developer of proprietary human 3D cell/tissue culture models for highly-predictive, multi-parameter phenotypic assays both in pharmacology safety & discovery screening and in personalized and regenerative medicine. IVS’s Functional 3D ...

ByInvivoSciences, Inc. (IVS)


First Patients in the U.S. Enrolled in Biosense Webster Clinical Study To Evaluate VARIPULSE™ Catheter for Atrial Fibrillation

First Patients in the U.S. Enrolled in Biosense Webster Clinical Study To Evaluate VARIPULSE™ Catheter for Atrial Fibrillation

Johnson & Johnson MedTech* announced today that Biosense Webster, Inc., a worldwide leader in the science and technology of cardiac arrhythmia treatment, enrolled the first patients in its admIRE clinical study in the United States. admIRE is a prospective, multi-center, non-randomized study that will enroll more than 400 patients in the U.S. to evaluate the safety and effectiveness of ...

ByJohnson & Johnson Medical Devices Business Services, Inc.


CD BioGlyco Released Separation of Glycosaminoglycans Service Recently

CD BioGlyco Released Separation of Glycosaminoglycans Service Recently

CD BioGlyco, a biotechnology company that provides glycobiology-related products, analysis, custom synthesis, and design to advance glycobiology research, recently announced the release of separation of Separation of Glycosaminoglycans service to the science community. Glycosaminoglycans, once known as mucopolysaccharides, are mainly found in the connective tissues of higher animals and plants. ...

ByCD BioGlyco.


Ted Davis to Succeed Amy Tseng as President and CEO of TissueTech

Ted Davis to Succeed Amy Tseng as President and CEO of TissueTech

TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, has named Ted Davis as the company’s new president and CEO. Davis—a seasoned biologics and orthopedics executive—takes the helm of an emerging company experiencing exponential growth, ...

ByBio-Tissue, Inc.


Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS

Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS

SPEARHEAD-1 trial will meet its primary endpoint and data will be used to support BLA filing for afami-cel next year The overall response rate (ORR) per Independent Review was 34% (36% in patients with synovial sarcoma and 25% for patients with MRCLS) and the disease control rate was 85% As of the data cut-off, afami-cel has shown a favorable benefit:risk profile Translational data confirm ...

ByAdaptimmune LLC


TissueTech Grows Sales Force to Support Footprint Expansion

TissueTech Grows Sales Force to Support Footprint Expansion

TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue allografts to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, announced today that they had completed a new round of hiring for their two commercial subsidiaries Bio-Tissue and Amniox Medical. The recently hired sales representatives and associate sales ...

ByBio-Tissue, Inc.


Bio-Tissue, Inc. Signs National Agreement with EyePro GPO to Afford Members Exclusive Treatment Options for Ocular Surface Disease and Disorders

Bio-Tissue, Inc. Signs National Agreement with EyePro GPO to Afford Members Exclusive Treatment Options for Ocular Surface Disease and Disorders

Bio-Tissue, Inc., a TissueTech company and pioneer in the clinical application of human birth tissue allografts to promote regenerative healing for ocular surface disease and disorders, announced today that it has entered into a Vendor Agreement with EyePro Group Purchasing Organization (GPO), LLC. As such, GPO members can now take advantage of membership purchasing volume discounts to access ...

ByBio-Tissue, Inc.


Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings

Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings

Clinical update and translational data from SPEARHEAD-1 in patients with synovial sarcoma and MRCLS to be presented at CTOS The Company will host its first virtual medical symposium at CTOS Translational data from Phase 1 SURPASS trial to be presented at SITC Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will present clinical and translational data ...

ByAdaptimmune LLC


SANUWAVE Rebrands to Reflect Evolved Wound Care Solutions

SANUWAVE Rebrands to Reflect Evolved Wound Care Solutions

SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. The new brand reflects the evolution of SANUWAVE’s solutions addressing the entire wound care pathway through its portfolio of noninvasive and ...

BySanuwave and Sanuwave Health, Inc.


FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications

FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications

Jointechlabs – a leader in point-of-care regenerative medicine therapies – today announced that the U.S. Food and Drug Administration (FDA) cleared the company’s MiniTCTM for point-of-care fat tissue processing designed to obtain microfat (or fat grafts), for multiple indications. Jointechlabs plans to focus on a range of therapeutic areas including medical aesthetics, plastic ...

ByJointechlabs Inc.


Serum 14-3-3? A Predictor Of Secondary Sjögren’s Syndrome In SLE

Serum 14-3-3? A Predictor Of Secondary Sjögren’s Syndrome In SLE

Do you have a patient with Systemic Lupus Erythematosus (SLE) that you suspect may also have Sjögren’s Syndrome (SS)? With shared clinical and serological features, overlapping SS with SLE is a comorbidity that is often challenging to identify to promptly assist clinical management. This may also lead to misdiagnoses of other connective tissue disorders. New data on 14-3-3η (eta) ...

ByAugurex Life Sciences Corp.


Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Never mind better insulin shots or cell implants for diabetics: Betalin Therapeutics has a unique approach. A young Israeli company that has cured type-1 diabetes in mice and hopes to do the same for humans one day has won the MIXiii Biomed 2017 pharma startup competition, beating dozens of other firms. Just how cured were these mice, exactly? “They were cured of advanced stages of severe ...

ByBetalin Therapeutics Ltd.


Just the (Fascia) Facts: Why Myofascial Release is so Beneficial

Just the (Fascia) Facts: Why Myofascial Release is so Beneficial

Fascia is the head-to-toe connective tissue that runs throughout the entire body. The fascia encompasses all the body’s internal structures, connecting everything together, even penetrating the muscles, organs and fatty tissues, and connecting bones to muscles and organs to each other. It looks like an extremely large spider web, with each thread connecting to another, which connects to ...

ByDSmedi, Inc.


10 Fascinating Facts About Myofascial Release (MFR)

10 Fascinating Facts About Myofascial Release (MFR)

Myo + Fascial + Release, or MFR Myo, meaning muscle, and fascia, the main connective tissue, account for almost all soft tissue in the body. That soft tissue can become damaged, creating restrictions which limit movement and create pain. “Release” refers to the gentle way in which myofascial release uses the natural qualities of fascia to release those restrictions, restoring ...

ByDSmedi, Inc.


Creative Bioarray Launched New Fibroblast Cells

Creative Bioarray Launched New Fibroblast Cells

Creative Bioarray 24th, August, 2016, launched some new fibroblast cells, along with the new cells products launch, the company released a promotion activity, aiming for providing some discouts at the beginning of autumn semester. Fibroblasts cells play an important role in wound healing, and they exist to boost the healing process. Though, there is still much to be probed as one of the most ...

ByCreative Bioarray


Congratulations to Dave Harry on his Swimathon 2015

Congratulations to Dave Harry on his Swimathon 2015

It’s been a tough but very worthwhile swimming journey for our Wales and West Contracts Manager Dave Harry who recently took part in Swimathon 2015 fundraising for Ehlers-Danlos syndrome. Dave successfully swam 5KM (3 miles) and raised £455 towards ongoing research into this condition – a huge thank you to everyone that sponsored and supported Dave along the way including his ...

ByEco Environmental Services Ltd

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT